Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
June 14, 2011 β New performance measures for adults with coronary artery disease (CAD) and hypertension were released ...
June 10, 2011 β The U.S. Food and Drug Administration (FDA) announced safety label changes for the cholesterol-lowering ...
June 3, 2011 β European CE mark approval was granted to expand use of the VerifyNow point-of-care P2Y12 test platelet ...
April 22, 2011 β A new study found that coronary artery bypass surgery added to medical therapy for selected ...
April 21, 2011 β A new angiotensin II receptor blocker (ARB) has been approved by the U.S. Food and Drug ...
April 21, 2011 β Baxter International has entered into a definitive agreement to acquire privately-held Prism ...
April 7, 2011 β Primary results from the RADAR Phase 2b clinical trial were announced at the American College of ...
April 7, 2011 β New study results have evaluated the potential inhibitory effects of certain proton pump ...
April 7, 2011 β Data from two phase 3 trials studying a drug for high-cholesterol patients who are on lipid ...
April 1, 2011 β Oral antiplatelet therapy Effient (prasugrel) has been added to the updated clinical practice ...
April 1, 2011 βResults from the RADAR Phase 2b clinical trial will be announced at the i2 Summit during the ...
March 25, 2011 β The American College of Cardiology (ACC) and the American Heart Association (AHA) have released a ...
March 11, 2011 β Sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, has another ...
March 10, 2011 β New guidelines have been published in The Annals of Thoracic Surgery that include point-of-care ...
June 30, 2011